Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Women with Endometrial and Ovarian Cancers Experience Significant Fatigue Following Surgery

August 28th 2020, 6:00pm

Article

Nearly half (48%) of the patients reported experiencing significant fatigue following their surgery. Thirty-nine percent of the patients still reported significant fatigue one year following their surgery.

CURE’s Clinical Trial Corner: August 2020

August 27th 2020, 1:00pm

Article

Here is a list of the recent trial initiations that occurred within the cancer space in August.

Mortality Rate of Patients with Gynecological Cancers and COVID-19 Similar to Age Specific Risk

August 18th 2020, 1:30pm

Article

While 75% of patients with gynecological cancers and COVID-19 will recover, new data from New York City shows specific risks for patients with cancer infected with COVID-19.

The Latest News and Updates in Ovarian Cancer

August 3rd 2020, 10:00pm

Article

A roundup of the latest news and updates for patients with ovarian cancer from CURE®.

Phase 3 Study of Tecentriq in Advanced Stage Ovarian Cancer Fails to Meet its Main Goal of Progression-Free Survival

July 14th 2020, 7:16pm

Article

Although the study failed to meet its goal of progression-free survival, overall survival data are currently not yet available, and follow-up will continue until the next planned analysis.

Surgical Removal of Fallopian Tubes to Prevent Ovarian Cancer Rapidly Rising, More Research Needed to Support Its Continued Use

July 14th 2020, 1:22am

Article

Ten percent of women who received a hysterectomy and salpingectomy, or removal of the fallopian tubes, during the study period had a family history of breast or ovarian cancer.

Certain Recurring Symptoms May Be Linked to Ovarian Cancer

July 13th 2020, 10:00pm

Article

A recent data analysis found that most women diagnosed with ovarian cancer (92%) experienced abdominal and pelvic-related symptoms and visited a physician with this complaint anywhere from six to 70 months prior to diagnosis.

Expert Discusses Therapeutic Options Taken At Home During COVID-19 Pandemic

July 7th 2020, 7:55pm

Article

Dr. Jubilee Brown discussed the use of telemedicine and oral treatment options for patients with ovarian cancer, as well as offered advice to ease stress and anxiety throughout the COVID-19 pandemic.

Combination of Mirvetuximab Soravtansine and Avastin Demonstrates Effective Outcomes in Recurrent Ovarian Cancer

June 15th 2020, 7:25pm

Article

The combination of mirvetuximab soravtansine and Avastin (bevacizumab) demonstrated encouraging overall response rates in patients with ovarian cancer, regardless of the disease’s previous responsiveness to platinum-based chemotherapy, according to data presented at the 2020 ASCO Virtual Scientific Program.

Lynparza-Cediranib Combination Produces Similar Activity to Standard of Care Chemotherapy in Ovarian Cancer

June 11th 2020, 1:00am

Article

The presentation of the complete data from the NRG-GY004 trial comes just months after AstraZeneca and Merck announced in a press release that the combination failed to meet its primary endpoint of progression-free survival.